The size of the Europe Electrophysiology Market was valued USD 1.72 billion in 2020 and is estimated to be growing at a CAGR of 9.43% to reach USD 2.71 billion by 2025.
Electrophysiology studies the electric properties of biological cells and tissues. Electrophysiology tests are performed to determine the functioning of the heart and to assess heart electric activity. It also helps finds arrhythmia in the heart and locates where it is coming from. The test is performed by inserting catheters and wire electrodes; this measure electrical activity through blood vessels that enter the heart. The duration of the electrophysiology test ranges from two hours to four hours.
European nation's majority of economic expenditure is spent on health care and medicine. Technological advancements also led to diagnostic market growth. The easy availability of slots and ease of communication made this marker easier. According to the European Heart Network AISBL reports, every year due to cardiovascular diseases, around 3.9 million deaths in Europe and over 1.8 million deaths in the European Union are reported. Hence increased heart patients and awareness on early detection of cardiovascular diseases increased market growth.
The market restraints hold back market growth and hamper the market size. In European nations, the number of electrophysiology diagnosis procedures and staff for the same is less comparatively. Medical specialists with a specialization in electrophysiology are scarce in EU countries. Hence the services are restricted to only a few places. There have been issues with supply and demand for devices related to electrophysiology diagnostics, and this hampered market growth. One more significant challenge for this market is that it is a high-cost issue for each unit, not affordable. And the cost and bill for these devices are not included under many healthcare plans and schemes; hence patients have to cover these devices bills from their own.
This research report has been segmented and sub-segmented the European Electrophysiology Market into the following categories:
By Product:
By Indication:
By Country:
Regionally, the European region has the second-largest market for electrophysiology in the world. Factors such as the rising geriatric population and advancements in technology are expected to propel the region's market growth. The European nation is the second-largest market for the electrophysiology market. Augmenting factors include a rise in the prevalence of heart diseases, stress-related issues causing cardiovascular diseases, and the geriatric population. The e-commerce sites and advertising sites increased the sale and supply of these devices and accelerated market growth.
In Germany, the research and advances for this market will fetch the market the highest growth. In these electrophysiology procedures, the medical staff and hospitals across Germany encourage usage of highly expensive multipolar catheters, which can be reprocessed. This reprocessing and use of materials is regulated by a government body that is the National health surveillance agency. Many other European countries like Russia and the United Kingdom follow this method as the expenditure for medical devices coverage, which will come under government funding to the health care sector.
Key players operating in the Europe Electrophysiology Market profiled in this report are Boston Scientific Corporation (U.S.), GE Healthcare (U.K.), Abbott Laboratories (U.S.), Biosense Webster, Inc. (U.S.), Microport Scientific Corporation (China), St. Jude Medical, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Koninklijke Philips N.V. (The Netherlands), Medtronic, Inc. (U.S.), and Siemens AG (Germany).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Electrophysiology Diagnostic Catheters
5.1.1.1 into Advanced Electrophysiology Diagnostic Catheters
5.1.1.2 Conventional Electrophysiology Diagnostic Catheters
5.1.1.3 Ultrasound Electrophysiology Diagnostic Catheters
5.1.2 Electrophysiology Ablation Catheters
5.1.2.1 Radiofrequency (RF) Ablation Catheters
5.1.2.2 Cryoablation Electrophysiology Catheters
5.1.2.3 Laser Ablation Systems
5.1.2.4 Microwave Ablation Systems
5.1.2.5 Navigational Advanced Mapping Accessories
5.1.3 Electrophysiology Laboratory Devices
5.1.3.1 Electrophysiology Recording Systems
5.1.3.2 3D Mapping Systems
5.1.3.3 Radiofrequency (RF) Ablation Generators
5.1.3.4 Electrophysiology X-Ray Systems
5.1.3.5 Intracardiac Echocardiography (ICE) Systems
5.1.3.6 Electrophysiology Remote Steering Systems
5.1.4 Access Devices
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Indication
5.2.1 Atrial Flutter
5.2.2 Atrial Fibrillation
5.2.3 Wolff-Parkinson-White Syndrome
5.2.4 Atrioventricular Nodal Re-entry Tachycardia
5.2.5 Other Indications
5.2.6 Y-o-Y Growth Analysis, By Indication
5.2.7 Market Attractiveness Analysis, By Indication
5.2.8 Market Share Analysis, By Indication
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Product
6.1.3.2 By Indication
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Product
6.1.4.2 By Indication
6.1.5 Market Share Analysis
6.1.5.1 By Product
6.1.5.2 By Indication
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Boston Scientific Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Abbott Laboratories
8.4 Biosense Webster, Inc.
8.5 Microport Scientific Corporation
8.6 St. Jude Medical, Inc.
8.7 BIOTRONIK SE & Co. KG
8.8 Koninklijke Philips N.V.
8.9 Medtronic, Inc.
8.10 Siemens AG
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
